AI Healthcare company Presagen, in collaboration with US Fertility and Ovation Fertility (USA) presented a study on Life Whisperer’s AI-based embryo assessment technology at the Asia Pacific Initiative on Reproduction (ASPIRE 2023), September 2023 in Adelaide, South Australia.
Life Whisperer uses Artificial Intelligence to non-invasively and instantly assess images of IVF patients’ embryos to evaluate their quality, with the aim of improving pregnancy outcomes. The study showed that Life Whisperer AI’s predictive ability outperformed 94% (220) of embryologists’ attempts for identifying whether embryos would eventually lead to a successful pregnancy outcome. The AI was able to correctly predict the likely pregnancy outcome for 14 out of 20 embryos. Only 6% (14) embryologists’ attempts achieved the same level of accuracy, and only one embryologist was able to beat the AI and achieve 15 correct predictions out of 20.
Importantly, the study showed that manual grading by embryologists was highly variable. Most embryologists’ accuracy ranged from 30% to 65%. The accuracy for the AI was 70%. Since the AI is a computer algorithm, it will always provide the exact same assessment for the exact same embryo image, thereby providing a more objective measure of embryo quality.
Subjectivity and variability with manual embryo grading can be a problem for large clinic networks that need to maintain a consistent and high quality of care for patients. The study demonstrated that AI has the potential to standardize embryo assessment, particularly for large clinic networks, and help “upskill” junior embryologists.
Life Whisperer is a world-leader in the application of AI in IVF. The Life Whisperer Viability and Genetics AI-based embryo assessment tools are the first to be commercialized in a series of applications that encompass the complete IVF journey. Life Whisperer aims to improve IVF success rates at every point and, as a result, reduce time-to-pregnancy, making IVF more affordable and accessible to patients globally. Life Whisperer is being used in IVF clinics around the world.
Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare products that are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership. With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility. With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.